Furthermore, EGCG from green tea inhibited the expression and activity of dipeptidyl peptidase 4 (DPP4), which is closely linked to the progression of hepatic steatosis and liver damage [55,57]. This evidence concerns the gene DPP4 and fatty liver disease.